Supply Chain

The Food and Drug Administration on Friday approved Portola Pharmaceuticals' oral blood thinner, betrixaban, reports Reuters.

GlaxoSmithKline will cease production of its seizure drug, Potiga, in mid-2017 due to low patient demand, reports Fox 61.

Regulatory leaders should make better use of available data during postapproval monitoring of medical devices, two researchers from the Ann Arbor-based University of Michigan Center for Healthcare Outcomes and Policy wrote in a JAMA analysis.

The following drug companies made headlines this past week.

Healthcare supply chains are moving towards more patient-focused operations in response to several trends. The prevalence of chronic disease, the continuum of sites in which patients receive care, growing consumer savvy in healthcare, and value-based payments are all affecting supply…

The healthcare technology company Philips will purchase Electrical Geodesics for about $36.7 million, reports the Portland Business Journal.

Senate Republicans on Thursday released a draft of their healthcare bill, which would permanently repeal the medical device tax, reports Regulatory Focus.

Here are the seven latest drugs or medical devices approved by the Food and Drug Administration since June 9.

The Food and Drug Administration on Thursday approved CSL Behring's injection to prevent hereditary angiodema attacks.

2017 has so far been a busy time for hospital mergers and acquisitions.